These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16210656)

  • 1. V gamma 9V delta 2 T cell response to colon carcinoma cells.
    Corvaisier M; Moreau-Aubry A; Diez E; Bennouna J; Mosnier JF; Scotet E; Bonneville M; Jotereau F
    J Immunol; 2005 Oct; 175(8):5481-8. PubMed ID: 16210656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
    Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
    J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
    Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
    Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.
    Trichet V; Benezech C; Dousset C; Gesnel MC; Bonneville M; Breathnach R
    J Immunol; 2006 Nov; 177(9):6129-36. PubMed ID: 17056540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
    Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
    J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
    Todaro M; D'Asaro M; Caccamo N; Iovino F; Francipane MG; Meraviglia S; Orlando V; La Mendola C; Gulotta G; Salerno A; Dieli F; Stassi G
    J Immunol; 2009 Jun; 182(11):7287-96. PubMed ID: 19454726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
    Nedellec S; Sabourin C; Bonneville M; Scotet E
    J Immunol; 2010 Jul; 185(1):55-63. PubMed ID: 20511557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
    Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
    Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells.
    Chauvin C; Joalland N; Perroteau J; Jarry U; Lafrance L; Willem C; Retière C; Oliver L; Gratas C; Gautreau-Rolland L; Saulquin X; Vallette FM; Vié H; Scotet E; Pecqueur C
    Clin Cancer Res; 2019 Dec; 25(23):7218-7228. PubMed ID: 31506386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.
    Le Maux Chansac B; Moretta A; Vergnon I; Opolon P; Lécluse Y; Grunenwald D; Kubin M; Soria JC; Chouaib S; Mami-Chouaib F
    J Immunol; 2005 Nov; 175(9):5790-8. PubMed ID: 16237071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen.
    Lafont V; Liautard J; Liautard JP; Favero J
    J Immunol; 2001 Jun; 166(12):7190-9. PubMed ID: 11390467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity.
    Todaro M; Orlando V; Cicero G; Caccamo N; Meraviglia S; Stassi G; Dieli F
    PLoS One; 2013; 8(6):e65145. PubMed ID: 23762301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V gamma 9V delta 2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect.
    Ottones F; Dornand J; Naroeni A; Liautard JP; Favero J
    J Immunol; 2000 Dec; 165(12):7133-9. PubMed ID: 11120844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of spontaneous cytotoxicity by human intestinal intraepithelial lymphocytes: MIC on colon cancer triggers NKG2D-mediated lysis through Fas ligand.
    Ebert EC; Groh V
    Immunology; 2008 May; 124(1):33-41. PubMed ID: 18284469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
    Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
    J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.